Table 3.
Outcomes not recommended for measuring and reporting by behavioural weight management interventions (BWMIs)
| Time Point | Outcome | Mean Panel Rating | Median Panel Rating |
|---|---|---|---|
| At baseline | Confidence in ability to lose weight | 6.4 | 7 |
| At follow‐up | Confidence in ability to lose weight | 6.4 | 7 |
| At follow‐up | Sedentary time | 6.4 | 7 |
| At follow‐up | Importance of weight loss | 6.4 | 7 |
| At baseline | Daily fruit and vegetable intake | 6.3 | 7 |
| At follow‐up | Fitness | 6.3 | 7 |
| At follow‐up | Mobility issues | 6.3 | 7 |
| At follow‐up | Disordered eating | 6.3 | 7 |
| At follow‐up | Anxiety | 6.3 | 7 |
| At baseline | Anxiety | 6.2 | 7 |
| At follow‐up | Waist circumference | 6.2 | 7 |
| At follow‐up | Leisure time physical activity | 6.2 | 7 |
| At follow‐up | Body image | 6.2 | 7 |
| At baseline | Leisure time physical activity | 6.1 | 7 |
| At follow‐up | Nonleisure time physical activity | 6.1 | 7 |
| At follow‐up | Daily fruit and vegetable intake | 6 | 7 |
| At baseline | Body image | 6 | 7 |
| At baseline | Nonleisure time physical activity | 6 | 7 |
| At baseline | Family history of obesity | 6 | 7 |
| At baseline | Smoking status | 6 | 7 |
| At baseline | Suicidal thoughts | 6 | 7 |
| At baseline | Sedentary time | 5.9 | 7 |
| At baseline | Fitness | 5.9 | 7 |
| At baseline | Weight loss history | 5.9 | 7 |
| At baseline | Daily alcohol consumption | 5.9 | 7 |
| At baseline | Asthma | 5.9 | 7 |
| At baseline | Other addictive behaviour | 5.9 | 7 |
| At follow‐up | Fat mass/body composition | 5.9 | 7 |
| At follow‐up | Daily calorie consumption | 5.9 | 7 |
| At follow‐up | Daily alcohol consumption | 5.8 | 7 |
| At baseline | Fat mass/body composition | 5.8 | 7 |
| At baseline | Daily calorie consumption | 5.8 | 7 |
| At follow‐up | Waist to hip ratio | 5.6 | 7 |
| At baseline | Waist circumference | 6.2 | 6 |
| At follow‐up | High cholesterol/lipids | 6.1 | 6 |
| At baseline | Advised To lose weight prior to routine surgery | 6 | 6 |
| At baseline | Osteoarthritis | 5.9 | 6 |
| At baseline | NAFLD | 5.9 | 6 |
| At follow‐up | Overall quality of sleep | 5.9 | 6 |
| At baseline | Overall quality of sleep | 5.8 | 6 |
| At baseline | Obstructive sleep apnoea | 5.8 | 6 |
| At baseline | Chronic back pain | 5.8 | 6 |
| At baseline | Other health conditions requiring a specialist diet | 5.8 | 6 |
| At follow‐up | Suicidal thoughts | 5.7 | 6 |
| At follow‐up | Obstructive sleep apnoea | 5.7 | 6 |
| At follow‐up | Other addictive behaviour | 5.6 | 6 |
| At follow‐up | Chronic back pain | 5.6 | 6 |
| At baseline | Chronic kidney disease | 5.6 | 6 |
| At baseline | Polycystic ovary syndrome (women only) | 5.6 | 6 |
| At baseline | Autism | 5.6 | 6 |
| At baseline | Personality disorders | 5.6 | 6 |
| At follow‐up | Daily free sugar intake | 5.6 | 6 |
| At follow‐up | Self‐reported reduction in clothes size | 5.5 | 6 |
| At follow‐up | Neck circumference | 4.9 | 5 |
| At baseline | Neck circumference | 4.7 | 5 |
Note. Outcomes rated by the expert panel as being least important with a mean rating less than 6.5 and a median rating less than or equal to 7 were designated as being “for exclusion” and would therefore not be recommended for measurement and reporting by BWMIs, unless participants gave a convincing argument for their recommendation during the round 3 Delphi.
Abbreviation: NAFLD, nonalcoholic fatty liver disease.